ITV's resident medical expert Dr Amir Khan has set social media ablaze after revealing his dramatic four-stone weight loss achieved using diabetes medication Mounjaro during an appearance on Lorraine.
The NHS doctor, a familiar face on the daytime show, openly discussed using the weekly injection—a drug similar to the controversial Ozempic—to manage his weight, prompting both admiration and concern from viewers.
Medical Miracle or Ethical Minefield?
The segment quickly divided the audience. While many praised Dr Khan's honesty and celebrated his improved health and confidence, others questioned the ethics of a medical professional using a drug primarily intended for diabetes patients for weight loss, especially amidst ongoing UK shortages.
"It's changed my life," Dr Khan told host Lorraine Kelly, detailing his journey. He emphasised that he sourced the drug privately through a regulated healthcare provider and underwent thorough medical checks, including heart scans, to ensure his safety.
A Nation's Weight Loss Debate Reignited
The conversation has tapped into the larger, heated debate surrounding GLP-1 receptor agonists like Ozempic and Wegovy. Proponents hail them as a revolutionary tool against obesity, while critics worry about side effects, long-term sustainability, and their impact on those with diabetes who rely on them.
Dr Khan addressed these concerns head-on, stating his belief that such medications should be more widely available on the NHS to help tackle the UK's obesity crisis, but only under strict medical supervision.
His revelation has ensured that the conversation about the future of weight management treatment is far from over, proving that personal health stories can spark national conversations.
